Quercetin attenuates LTA-induced tight junction disruption in mammary epithelial cells by modulating autophagy via

Liangli Song1, Xiangchen Li1, Linnan Wang1

  • 1College of Animal Science & Technology, Ningxia University, Yinchuan 750021, China.

Mastitis in dairy cows impairs lactation and limits the development of the dairy industry. Lipoteichoic acid (LTA), a virulence factor of Staphylococcus aureus, disrupts the blood-milk barrier in the mammary gland. Quercetin, known for its anti-inflammatory and antibacterial properties, was evaluated for its protective effects against LTA-induced tight junction (TJ) injury. We established a TJ injury model using LTA-treated MAC-T cells (a mammary epithelial cell line) and mouse mammary tissue. Results demonstrated that LTA compromised TJ integrity and induced dysregulated autophagy in MAC-T cells. Notably, quercetin treatment was associated with the inhibition of this autophagic dysregulation and attenuated the LTA-induced disruption of TJ protein expression. Further mechanistic studies revealed that both quercetin and Compound C (CC, an AMPK inhibitor) reduced autophagy levels and mitigated the LTA-induced decline in key TJ proteins, suggesting that quercetin is associated with the attenuation of LTA-induced TJ integrity disruption under inflammatory stress, which correlates with modulated changes in AMPK phosphorylation and the mTOR signaling pathway. In vivo mouse experiments confirmed that quercetin acts as a dual-action modulator that regulates baseline signaling while attenuating LTA-induced TJ protein damage. This protective process is mediated through the modulation of AMPK/mTOR-dependent autophagy, thereby suppressing LTA-induced autophagic dysregulation. These findings provide a theoretical basis for further research into alternative, non-antibiotic strategies for mastitis control.

Related Concept Videos

Tight Junctions01:29

Tight Junctions

Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...